Full text is available at the source.
Abstract
A single-step duplex CRISPR assay can detect both HIV and Treponema pallidum in whole blood within 30 minutes with a limit of detection of 2.5 copies/µL.
- The assay integrates multiple processes, including reverse transcription and nucleic acid amplification, for simultaneous testing.
- A low-cost microfluidic chip enables rapid plasma separation and nucleic acid release without the need for external equipment.
- The system demonstrates 100% sensitivity and specificity when compared to real-time PCR in 51 clinical samples.
- A smartphone-based portable device facilitates thermal incubation and automated image analysis for user convenience.
- The approach offers a potential solution for decentralized and efficient pathogen testing.
Simplified